Marshall Wace, LLP Liquidia Corp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Liquidia Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 286,289 shares of LQDA stock, worth $4.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286,289
Previous 148,696
92.53%
Holding current value
$4.61 Million
Previous $1.49 Million
126.51%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LQDA
# of Institutions
188Shares Held
44.8MCall Options Held
1.22MPut Options Held
1.09M-
Black Rock Inc. New York, NY4.24MShares$68.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$57.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$53 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$49.6 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$36.5 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.04B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...